This medical technology is not from Star Trek! It's real! Healthcare will never be the same again! A true game changer!

                     

GoForward, commonly known as Forward, 

is a healthcare company that aims to revolutionize the way people access and manage their health. Founded by former executives from Google and Uber, including Adrian Aoun, Forward integrates advanced technology with personalized medical care to provide a more proactive and preventive approach to health management.

Technology and Services:

• Artificial Intelligence and Machine Learning: Forward utilizes AI to analyze vast amounts of health data, helping physicians make more informed decisions and predict potential health issues before they become serious.
• Real-Time Health Monitoring: Members have access to devices like body scanners and wearable sensors that continuously monitor vital signs, allowing for immediate detection of anomalies.
• Personalized Health Plans: Using data from genetic testing, blood tests, and lifestyle information, Forward creates customized wellness plans tailored to individual needs.
• Telemedicine and App Integration: The Forward app enables patients to book appointments, access their health data, and communicate with their medical team remotely.

The company's goal is to shift healthcare from a reactive model—treating illnesses as they occur—to a proactive one that emphasizes prevention and early detection.

Going Public?

Forward remains a privately held company. There have been no official announcements regarding plans to go public or initiate an Initial Public Offering (IPO). For the most current information on Forward's corporate developments, it's advisable to follow official company communications or check reliable financial news sources.

The "GoForward pod," commonly known as the Forward pod,

goforward.com/carepod-announce

is a central feature of Forward's high-tech healthcare clinics. It is a private, technology-enhanced examination room designed to revolutionize the traditional doctor's visit by integrating advanced medical technology with personalized patient care.

Key Features of the Forward Pod:

1. Interactive Touchscreens:

   • Large displays allow both the patient and the physician to view and interact with health data in real-time.
   • Visualizations of medical history, test results, and health metrics facilitate better understanding and engagement.

2. Body Scanner and Integrated Diagnostics:

   • Non-invasive body scanners collect vital signs such as heart rate, blood pressure, temperature, and oxygen saturation within seconds.
   • Additional devices like EKGs and spirometers are seamlessly integrated to provide comprehensive health assessments.

3. Artificial Intelligence and Data Analytics:

   • AI algorithms analyze collected data to identify patterns or potential health concerns.
   • Predictive analytics help in early detection of conditions and personalized preventive care recommendations.

4. Real-Time Data Integration:

   • Immediate syncing of data with the Forward app allows patients to access their health information anytime.
   • Physicians can track changes over time, enabling more accurate diagnoses and tailored treatment plans.

5. Comfortable and Modern Design:

   • The pods are designed to create a calming environment, reducing the stress often associated with medical visits.
   • The modern aesthetic reflects Forward's commitment to innovation and patient-centered care.

Benefits of the Forward Pod:

• Enhanced Patient Engagement: The interactive technology empowers patients to take an active role in their health management.
• Efficiency: Streamlined data collection and analysis reduce wait times and make appointments more efficient.
• Preventive Focus: By facilitating early detection and continuous monitoring, the pods support Forward's goal of proactive healthcare.
• Personalized Care: Data-driven insights enable physicians to create customized health plans based on each individual's unique needs.

Conclusion:

The GoForward pod exemplifies Forward's innovative approach to transforming healthcare. By integrating cutting-edge technology with personalized medical care, the pods aim to make healthcare more efficient, engaging, and preventive, ultimately improving patient outcomes and experiences.

There are videos available that showcase the Forward pod and its innovative features. These videos provide a visual demonstration of how Forward integrates advanced technology into their healthcare services, highlighting elements such as:

• Interactive Touchscreens: See how patients and physicians interact with real-time health data during consultations.
• Body Scanners and Diagnostic Tools: Watch how vital signs are quickly collected and analyzed using non-invasive devices.
• Patient Experience: Get a sense of the modern and comfortable environment designed to enhance the overall healthcare experience.

Where to Find the Videos:

Click to watch the video at GoForward

• Forward's Official Website: Visit goforward.com to find promotional videos and virtual tours of their clinics.
• YouTube Channel: Forward often shares videos on their YouTube channel featuring demonstrations and patient testimonials.
• News and Media Outlets: Several tech and health news organizations have covered Forward, including video segments. Searching for "Forward Health pod video" or similar terms can help you find these features.
• Social Media Platforms: Check Forward's official accounts on platforms like Instagram, Twitter, and LinkedIn for short videos and clips highlighting the pod's functionalities.

These videos can give you a comprehensive understanding of how the Forward pod operates and how it aims to transform the traditional healthcare experience through technology.

Healthcare will never be the same!

Editor Note: GoForward is still a privately held company!

E.L.F. Cosmetics is a growing phenomenon in the Cosmetics industry. Leading the way in Cruelty Free products that are affordable 

Cures for antoimmune diseases such as MD, Lupus, Mytosis MS and others are targets for this cutting edge, Bio Tech microcap!

Recursion Pharmaceuticals is at the forefront of AI-driven drug discovery!

 Recursion Pharmaceuticals has caught the attention of major pharmaceutical companies due to its innovative approach to drug discovery. More recently, nVidia bought $70 Million of shares in $RXRX

Here’s why it’s worth knowing about:

1. AI-Driven Drug Discovery:

   Recursion collaborates with major biopharma companies to reduce research and development (R&D) costs and timelines. It employs AI-enabled methods to identify promising biological targets and molecules. By using digital chemistry and machine learning, Recursion calculates potential drug development targets efficiently.

2. Massive Data Repository:

   Recursion maintains an extensive database with over 3.1 trillion relationships between chemical and biological components. This data helps identify potential drug targets and streamline the drug discovery process.

3. Recent Acquisitions:

   Recursion recently acquired AI-related biotechs, Cyclica and Valence, which will enhance its drug discovery capabilities. These acquisitions aim to make Recursion even more effective at identifying drug targets and collaborating with pharmaceutical companies1.

4. Existing Collaborations:

    As we pointed out, powerful players like Roche and Bayer are already among Recursion’s patrons. Collaborating with Recursion allows these companies to leverage AI-driven approaches for drug discovery2.

5. Rare Disease Pipeline:

   Recursion also has its own development pipeline, including three programs in phase 2 clinical trials for rare diseases. For example, one program targets neurofibromatosis type 2, a condition affecting only 33,000 people worldwide. These pipeline projects could significantly boost Recursion’s revenue in the long term

6. Recursion Pharmaceuticals (RXRX on the Nasdaq)
7. offers a unique blend of AI-driven drug discovery, a vast data repository, and promising collaborations, making it an attractive partner for big pharmaceutical companies

Recursion Pharmaceuticals collaborates with NVIDIA to accelerate drug discovery using AI technology. Their newest supercomputer, BioHive-2, powered by 504 NVIDIA H100 Tensor Core GPUs, delivers 2 exaflops of AI performance—nearly 5x faster than their previous system.

Latest news:

Recursion Pharmaceuticals, Inc. - Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry

Recursion ($RXRX)

Has developed an impressive artificial intelligence system called BioHive-2, which is powered by NVIDIA AI.  

 This supercomputer is specifically designed to accelerate drug discovery in the field of biology.

 

Let me share some details about it:

1. BioHive-2: Recursion’s BioHive-2 is the largest system in the pharmaceutical industry. It’s located at Recursion’s headquarters in Salt Lake City.

   This supercomputer ranks No. 35 on the latest TOP500 list of the world’s fastest supercomputers. 

2. It’s a significant improvement over its predecessor, BioHive-1, and delivers an impressive 2 exaflops of AI performance1.

3. AI in Drug Discovery: Recursion uses AI models on BioHive-2 to accelerate drug discovery. The field of biology is incredibly complex, and finding new drug candidates often involves years of wet-lab experiments.

   Recursion’s scientists can now run over 2 million experiments per week! 

4. With AI assistance, they can focus on the most promising areas, significantly reducing the need for extensive wet lab work. The goal is to achieve 80% of the value with only 40% of the experiments, thanks to AI-guided decision-making.

5. Massive Biological Dataset: Recursion collaborates with biopharma companies like Bayer AG, Roche, and Genentech. Over time, they’ve built a 50-petabyte database containing biological, chemical, and patient data. 

6. This vast dataset fuels powerful AI models that accelerate drug discovery. In fact, Recursion believes it’s one of the largest biological datasets globally, intentionally spanning both biology and chemistry.

7. Phenom Models: Using BioHive-1, Recursion developed a family of foundation models called Phenom. These models transform microscopic cellular images into meaningful representations for understanding underlying biology. 

8. Phenom-Beta, a member of this family, is now available as a cloud API and the first third-party model on NVIDIA BioNeMo, a generative AI platform for drug discovery1.

In summary, Recursion’s AI-driven approach is revolutionizing drug discovery by leveraging massive datasets, powerful AI models, and BioHive-2’s computational prowess. 

Their work has the potential to transform our understanding of biology and improve patients’ lives through better drug treatments

Disclosure: we are long $RXRX

"The rapid and complete resolution of aggressive MSS colorectal cancer tumors observed in this study is unprecedented in the field" says the author Dr. Kasi

Adaptive Biotechnologies (ADPT on Nasdaq) is making significant advancements in biotechnology, focusing on harnessing the adaptive immune system for diagnosing and treating diseases